Does Topical Lidocaine Reduce The Amount of Intravenous Conscious Sedation Required To Complete Diagnostic Upper Endoscopy and Shorten Recovery Time? A Double Blinded, Randomized, Placebo Controlled Study.
Overview
- Phase
- Not Applicable
- Intervention
- Placebo
- Conditions
- Dysphagia
- Sponsor
- Brooke Army Medical Center
- Enrollment
- 106
- Locations
- 1
- Primary Endpoint
- Amount of sedation used
- Last Updated
- 10 years ago
Overview
Brief Summary
Patients will be randomized to a placebo or study group who will receive topical lidocaine prior to EGD. Amount of medication used, recovery time, patient/endoscopist satisfaction will then be assessed.
Detailed Description
The study will be a double blinded randomized placebo controlled trial Patients between 18 and 89 years old who are scheduled for EGD may be eligible to enroll in the study. Potential subjects will be sought through referral by their treating attending and fellow gastroenterologist, who will be apprised of the inclusion and exclusion criteria. Patients possibly meeting inclusive and exclusive criteria will be approached and discussed the study further with the investigators. Those expressing a desire to participate in the study will be given written informed consent prior to participation. The investigators will enroll patients into the study with a goal of at least 53 patients in each group which is the number of patients our statistician recommended to appropriately power our study. Patients who consent to enroll in the study will be randomized into 2 groups. Group 1: Swish and swallow 10ml of 2% lidocaine solution Group 2: Swish and swallow 10ml of 0.45% sodium chloride solution The patients will then undergo endoscopy for the indication identified in their clinic appointment. Following the procedure, patients will be taken to the recovery area and recovered per clinic protocol. The endoscopist will complete a satisfaction questionnaire. The day following the procedure a nurse will call to check for post-operative complications per clinic protocol. The day following, an investigator will also call to perform a patient satisfaction survey..
Investigators
Adam Tritsch
Gastroenterology Fellow
Brooke Army Medical Center
Eligibility Criteria
Inclusion Criteria
- •EGD alone performed by staff gastroenterologist as an outpatient
- •Between the age of 18 and 89
- •Not requiring anesthesia support or use of medications other than fentanyl and midazolam
Exclusion Criteria
- •Prior history of head and neck surgery
- •Known hypersensitivity to local anesthetics, the amide type or any components of the topical lidocaine
- •Patients having interventions other than polypectomy performed
- •Pregnant or breast feeding females
- •Patients with severe liver impairment
- •Known hypersensitivity to benzodiazepine or fentanyl
Arms & Interventions
Placebo
Patients will receive 10cc of 1/2 normal saline to gargle prior to EGD
Intervention: Placebo
Experimental
Patients will receive 10cc of 2% topical lidocaine to gargle prior to EGD
Intervention: Lidocaine
Outcomes
Primary Outcomes
Amount of sedation used
Time Frame: 60 minutes
We will record the amount of sedation used during the procedure
Secondary Outcomes
- Recovery time(120 minutes)
- Patient and physician satisfaction(24 hours)